期刊文献+

隐匿性乙型肝炎病毒感染与输血传播研究进展

Research progress in occult hepatitis B virus infection and its transmission via blood transfusion
原文传递
导出
摘要 近年来随着核酸检测技术的发展,输血传播乙型肝炎病毒(HBV)的风险已显著降低,但仍有输血传播残余风险。献血筛查中暴露的隐匿性HBV感染问题日益受到关注。本文从隐匿性HBV感染的流行病学特征、感染机制、传统和新型诊断标志物、输血传播风险因素与残余风险评估等方面进行综述,以期为提高血液检测质量,降低HBV输血传播风险,确保献血者血液安全提供借鉴。 In recent years,the development of nucleic acid testing(NAT)have significantly reduced the risk of hepatitis B virus(HBV)transmission through blood transfusion.However,a residual risk persists.Occult hepatitis B virus infection(OBI),identified during blood donor screening,has become a growing concern for transfusion safety.This review summarizes the epidemiological characteristics,infection mechanism,traditional and novel diagnostic markers,risk factors for transfusion transmission,and assessments of residual risk of OBI,in order to provide reference for improving the quality of blood screening,reducing the risk of HBV transfusion transmission and ensuring the blood safety of blood donors.
作者 王蕊 王波 于洋 WANG Rui;WANG Bo;YU Yang(Department of Transfusion Medicine,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China;The Southern Medical Branch of PLA General Hospital,Beijing 100071,China)
出处 《中国输血杂志》 2025年第11期1627-1633,共7页 Chinese Journal of Blood Transfusion
关键词 隐匿性乙型肝炎病毒感染 CCCDNA 输血传播 occult hepatitis B virus infection(OBI) cccDNA transfusion transmission
  • 相关文献

参考文献2

二级参考文献81

  • 1Evangelista Sagnelli,Mariantonietta Pisaturo,Salvatore Martini,Pietro Filippini,Caterina Sagnelli,Nicola Coppola.Clinical impact of occult hepatitis B virus infection in immunosuppressed patients[J].World Journal of Hepatology,2014,6(6):384-393. 被引量:4
  • 2Vedat Goral,Hamza Ozkul,Selahattin Tekes,Dede Sit,Ali Kemal Kadiroglu.Prevalence of occult HBV infection in haemodialysis patients with chronic HCV[J].World Journal of Gastroenterology,2006,12(21):3420-3424. 被引量:7
  • 3Mohammad Javad Kaviani,Behzad Behbahani,Mohammad Jafar Mosallaii,Fatemeh Sari-Aslani,Seyed Alireza Taghavi.Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection[J].World Journal of Gastroenterology,2006,12(31):5048-5050. 被引量:6
  • 4Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Gilcher RO,Ownby HE, Schreiber GB. A method for estimating hepatitis Bvirus incidence rates in volunteer blood donors. National Heart,Lung, and Blood Institute Retrovirus Epidemiology Donor Study.Transfusion 1997; 37: 634-640 [PMID: 9191825].
  • 5Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. TransfusiontransmittedHBV infection in an endemic area: the necessity ofmore sensitive screening for HBV carriers. Transfusion 2002; 42:1592-1597 [PMID: 12473140].
  • 6Candotti D, Allain JP. Transfusion-transmitted hepatitis B virusinfection. J Hepatol 2009; 51: 798-809 [PMID: 19615780 DOI:10.1016/j.jhep.2009.05.020].
  • 7Perkins HA, Busch MP. Transfusion-associated infections:50 years of relentless challenges and remarkable progress.Transfusion 2010; 50: 2080-2099 [PMID: 20738828 DOI: 10.1111/j.1537-2995.2010.02851.x].
  • 8Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W,Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBctesting increase blood safety. Transfusion 2002; 42: 869-875 [PMID:12375659].
  • 9Cable R, Lelie N, Bird A. Reduction of the risk of transfusiontransmittedviral infection by nucleic acid amplificationtesting in the Western Cape of South Africa: a 5-year review.Vox Sang 2013; 104: 93-99 [PMID: 22924987 DOI: 10.1111/j.1423-0410.2012.01640.x].
  • 10Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS,Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH,Levrero M, Locarnini S, Michalak T, Mondelli MU, PawlotskyJM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, SmedileA, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F.Statements from the Taormina expert meeting on occult hepatitisB virus infection. J Hepatol 2008; 49: 652-657 [PMID: 18715666DOI: 10.1016/j.jhep.2008.07.014].

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部